fda warning about semaglutide The sent a letter to the maker of Ozempic and Wegovy over unreported potential GLP-1 side effects. Here's what to know black box warning for semaglutide

BPI Labs is launching a number of 503B injectable products, the lawsuit warned, claiming the facility was built to produce large batches with or without prescriptions. The case settled on May 21, according to PACER

Ozempic (semaglutide) is a prescription medicine used to improve blood sugar control in adults with type 2 diabetes mellitus

Pancreatic beta-cell signaling: toward better understanding of diabetes and its treatment

Yet, performing long-term toxicology studies and dietary intervention trials for each new nano-formulation is resource-intensive, and regulatory agencies have not fully standardized the requirements

Additionally, Schisandrol B alleviates diabetic cardiac injury by upregulating p53 to inhibit ferroptosis and improve lipid metabolism [115]